A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers
Trials - United Kingdom
doi 10.1186/s13063-016-1489-8
Full Text
Open PDFAbstract
Available in full text
Date
July 28, 2016
Authors
Publisher
Springer Science and Business Media LLC